# Bioequivalence Study of Metformin 750 mg Tablets XR Versus Glucophage® Long 750 mg Tablets XR In Normal Healthy Subjects Under Fasting and Fed Conditions

> **NCT03452306** · PHASE1 · COMPLETED · sponsor: **Geropharm** · enrollment: 28 (actual)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** Metformine
- **DRUG:** Glucophage® Long
- **DRUG:** Metformin
- **DRUG:** Glucophage® Long

## Key facts

- **NCT ID:** NCT03452306
- **Lead sponsor:** Geropharm
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-15
- **Primary completion:** 2017-07-22
- **Final completion:** 2017-07-22
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2018-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03452306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03452306, "Bioequivalence Study of Metformin 750 mg Tablets XR Versus Glucophage® Long 750 mg Tablets XR In Normal Healthy Subjects Under Fasting and Fed Conditions". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03452306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*